TrialCancer2009

Phase 2 trial of sorafenib in patients with advanced urothelial cancer: a trial of the Eastern Cooperative Oncology Group.

Robert Dreicer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.